CTLFX
Price
$14.02
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Net Assets
4.15B
RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

CTLFX vs RLEFX

Header iconCTLFX vs RLEFX Comparison
Open Charts CTLFX vs RLEFXBanner chart's image
American Funds College 2033 529F1
Price$14.02
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.15B
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
CTLFX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
CTLFX vs. RLEFX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTLFX is a Hold and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. CTLFX (4.15B). CTLFX pays higher dividends than RLEFX: CTLFX (2.60) vs RLEFX (1.92). CTLFX was incepted earlier than RLEFX: CTLFX (11 years) vs RLEFX (10 years). CTLFX (0.76) is less costly to investors than RLEFX (0.39). RLEFX is a more actively managed with annual turnover of: 44.00 vs. CTLFX (6.00). CTLFX (250) and RLEFX (250) have matching initial minimum investment requirements. CTLFX annual gain was more profitable for investors over the last year : 9.54 vs. RLEFX (8.94). RLEFX return over 5 years is better than : 43.26 vs. CTLFX (20.22).
CTLFXRLEFXCTLFX / RLEFX
Total Expense Ratio0.760.39195%
Annual Report Gross Expense Ratio0.760.39195%
Fund Existence11 years10 years-
Gain YTD12.34014.81983%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.15B265B2%
Annual Yield % from dividends2.601.92135%
Returns for 1 year9.548.94107%
Returns for 3 years44.2351.3986%
Returns for 5 years20.2243.2647%
Returns for 10 years71.62N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc